leadf
logo-loader
viewMylan Inc.

Mylan, Vantiv,Achillion Pharmaceuticals and more - PRE-MARKET

A look at what's hot and what's not before the bell in New York

stockmarket
Stockwatchers in New York - the Wall Street trading floor

With US futures pointing to a lower open as global markets are taking a knock from President Trump's comments over North Korea and mounting tension, several stocks are in play before the bell.

Vantiv Inc shares shed around 0.48% after the bell as it emerged that it had sealed its $10.4bn meger with London listed giant Worldpay.

Vantiv offered 55 pence in cash for each Worldpay share, an interim divi of 0.8 pence per Worldpay share, and a special divi of 4.2 pence per share, and the deal will create a combined entity worth almost US$29bn.

Elsewhere, Mylan NV (NASDAQ:MYL) shed 7.71% in pre-market deals to US$29.30 as it posted downbeat second quarter results and issued a weak full year 2017 outlook.

Earnings rose to US$297mln from US$168.4mln last year. Adjusted earnings-per-share were US$1.10, below consensus estimates of US$1.16.

 

Also tanking before the bell was fashion and manufacturing firm Fossil Group Inc (NASDAQ:FOSL), down 21.96% to US$9.24, as it reported a big second quarter loss and the departure of its finance chief.

Meanwhile, Childrens Place Inc (NASDAQ: PLCE), the kids clothing retailer, saw shares lose  over 4% in pre-market to US$113.14 as it reported the appointment of Steven G. Rado to the position of chief digital officer with effect from August 14 this year.

Elsewhere, Achillion Pharmaceuticals Inc (NASDAQ:ACHN) raced up over 21% to US$4.88 before the bell as second-quarter losses at the New Haven-based drugmaker increased by 21.6% to US$22.5mln, which was in-line with expectations.

Quick facts: Mylan Inc.

Price: 14.37 USD

NASDAQ:MYL
Market: NASDAQ
Market Cap: $7.43 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

archTIS makes transformative move in acquiring Nucleus Cyber

archTIS (ASX: AR9) CEO Daniel Lai joins Steve Darling from Proactive to share details of a transformative acquisition with the company entering a binding term sheet to acquire global information protection business Nucleus Cyber. Lai discusses why this is a key move for the company...

13 hours, 16 minutes ago

2 min read